Option Care Health (NASDAQ:OPCH – Get Free Report) was upgraded by Jefferies Financial Group from a “hold” rating to a “buy” rating in a research report issued on Thursday, MarketBeat reports. The brokerage presently has a $35.00 price objective on the stock, up from their prior price objective of $26.00. Jefferies Financial Group’s price target suggests a potential upside of 15.40% from the company’s previous close.
Several other analysts have also commented on the company. The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $38.00 to $27.00 in a report on Monday, November 4th. JMP Securities reissued a “market outperform” rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. UBS Group started coverage on Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target for the company. Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and increased their price target for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Finally, Barrington Research boosted their price objective on Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a research report on Tuesday, January 14th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, Option Care Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $32.25.
Read Our Latest Stock Report on OPCH
Option Care Health Trading Up 1.1 %
Insider Activity at Option Care Health
In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the firm’s stock in a transaction dated Friday, November 8th. The shares were purchased at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now owns 326,334 shares in the company, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. 0.64% of the stock is owned by corporate insiders.
Institutional Trading of Option Care Health
Hedge funds have recently bought and sold shares of the business. UMB Bank n.a. grew its position in shares of Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after purchasing an additional 750 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after acquiring an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. raised its holdings in shares of Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after acquiring an additional 1,446 shares during the period. International Assets Investment Management LLC raised its holdings in shares of Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after acquiring an additional 2,757 shares during the period. Finally, Quarry LP boosted its position in shares of Option Care Health by 327.7% during the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after acquiring an additional 2,628 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.
Option Care Health Company Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
- Five stocks we like better than Option Care Health
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- How to Calculate Stock Profit
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Find and Profitably Trade Stocks at 52-Week Lows
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.